Drugs / Lymecycline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00988026 | Jun 2009 → Feb 2010 | adult acne | Darier | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT06447480 Comparator | Apr 2025 → Sep 2027 expected | acne | Centre Hospitalier Universitaire de Nice | Recruiting | No outcome recorded |
| Phase 3 | NCT01014689 Comparator | Aug 2009 → Apr 2010 | acne | Galderma R&D | Completed | No outcome recorded |
| Phase 4 | NCT01661985 Comparator | Feb 2010 → Aug 2015 | Mycoplasmoides infection, cervicitis, chlamydia trachomatis infectious disease, urethritis | Ostergotland County Council, Sweden | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lymecycline | “topical tretinoin or adapalene once daily (every other day if irritation) with doxycycline or lymecycline 100 mg/d” NCT06447480 ↗ |
| Route | Oral | “Lymecycline 300 mg OD per mouth for 8 weeks.” NCT00988026 ↗ |